STX
45
-4
BK
74
3
RL
69
-4
HCP
56
-8
ESS
62
-3
MSFT
46
-11
IR
63
-3
TJX
62
-2
CI
45
-3
WHR
65
-5
R
70
-3
EA
60
-5
XYL
35
-2
JNJ
41
3
OI
42
-3
PG
50
2
LEN
50
-2
STI
45
26
SWK
50
-5
WDC
37
-3
STX
45
-4
BK
74
3
RL
69
-4
HCP
56
-8
ESS
62
-3
MSFT
46
-11
IR
63
-3
TJX
62
-2
CI
45
-3
WHR
65
-5
R
70
-3
EA
60
-5
XYL
35
-2
JNJ
41
3
OI
42
-3
PG
50
2
LEN
50
-2
STI
45
26
SWK
50
-5
WDC
37
-3
Financhill
Back

Roivant Sciences Vs. Biodexa Pharmaceuticals PLC Industry Stock Comparison

Sell
34

ROIV
Roivant Sciences

Last Price:
11.16
Seasonality Move:
19.8%
Sell
20

BDRX
Biodexa Pharmaceuticals PLC

Last Price:
3.65
Seasonality Move:
-24.92%
Sell
34
Roivant Sciences (ROIV) is a Sell

Is Roivant Sciences a Buy, Sell or Hold?

  • The current Roivant Sciences [ROIV] share price is $11.20. The Score for ROIV is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • ROIV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
Biodexa Pharmaceuticals PLC (BDRX) is a Sell

Is Biodexa Pharmaceuticals PLC a Buy, Sell or Hold?

  • The current Biodexa Pharmaceuticals PLC [BDRX] share price is $3.62. The Score for BDRX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • BDRX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

ROIV Stock Price Chart

What is Roivant Sciences's stock price today?

  • The Roivant Sciences share price today is $11.20
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ROIV is experiencing selling pressure, which indicates risk of future bearish movement.

BDRX Stock Price Chart

What is Biodexa Pharmaceuticals PLC's stock price today?

  • The Biodexa Pharmaceuticals PLC share price today is $3.62
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDRX is experiencing selling pressure, which indicates risk of future bearish movement.

ROIV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 39.17 Sell
Chaikin Money Flow: -6225460 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.57 - 11.91) Sell
Bollinger Bands (100): (10.92 - 11.98) Sell

BDRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.09 Buy
Relative Strength Index (14 RSI): 28.13 Sell
Chaikin Money Flow: -53327 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.89 - 6.69) Sell
Bollinger Bands (100): (-0.22 - 4.62) Buy

ROIV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.7 Sell
20-day SMA: 11.7 Sell
50-day SMA: 11.76 Sell
200-day SMA: 11.18 Buy
8-day EMA: 11.62 Sell
20-day EMA: 11.68 Sell
50-day EMA: 11.65 Sell
200-day EMA: 11.16 Buy

BDRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.02 Sell
20-day SMA: 5.75 Sell
50-day SMA: 3.68 Sell
200-day SMA: 1.68 Buy
8-day EMA: 4.87 Sell
20-day EMA: 5.16 Sell
50-day EMA: 4.14 Sell
200-day EMA: 12.55 Sell

Roivant Sciences Earnings Growth & ROIV Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.35 per share, and an increase next year of $0.23 per share.

Biodexa Pharmaceuticals PLC Earnings Growth & BDRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.05 per share.

Roivant Sciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biodexa Pharmaceuticals PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):